Finance Home - My Yahoo - Yahoo! - Help

Sunday, December 20, 2009, 12:29PM ET - U.S. Markets Closed. Dow  0.20% Nasdaq  1.45%

LORUS THERAPEUTICS NEW COM NPV (LOR.TO)

On Dec 18: 0.07   0.005 (7.69%)

MORE ON LOR.TO

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Nov 30, 2009 • Lorus Therapeutics Announces Positive Result in Its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukemia (AML) CCNMatthews (Mon, Nov 30) Fri, Nov 27, 2009 • Lorus Therapeutics Raises $2.46 Million in Equity Financing CCNMatthews (Fri, Nov 27) Tue, Oct 6, 2009 • Lorus Therapeutics Reports First Quarter Results for Fiscal Year 2010 CCNMatthews (Tue, Oct 6) Mon, Sep 21, 2009 • Lorus Announces Publication Supporting Novel Mode of Anticancer Therapy for LOR-253 Class of Compounds CCNMatthews (Mon, Sep 21) Wed, Aug 5, 2009 • Lorus Therapeutics Announces Allowance of Patent for LOR-2040 in Japan CCNMatthews (Wed, Aug 5) Mon, Jul 27, 2009 • Lorus Therapeutics Reports Results for Fiscal Year 2009 CCNMatthews (Mon, Jul 27) Mon, Jun 29, 2009 • Lorus Announces Publication of a Novel Analytical Method Confirming the Pharmacological Action of Its Anticancer Drug LOR-2040 CCNMatthews (Mon, Jun 29) • Lorus Announces Publication of a Novel Analytical Method Confirming the Pharmacological Action of Its Anticancer Drug LOR-2040 Marketwire (Mon, Jun 29) Mon, Jun 22, 2009 • Lorus Therapeutics Announces Settlement of Secured Convertible Debentures CCNMatthews (Mon, Jun 22) • Lorus Therapeutics Announces Settlement of Secured Convertible Debentures Marketwire (Mon, Jun 22) Tue, May 19, 2009 • Lorus Therapeutics Announces a Cooperative Research and Development Agreement With the U.S. National Cancer Institute CCNMatthews (Tue, May 19) • Lorus Therapeutics Announces a Cooperative Research and Development Agreement With the U.S. National Cancer Institute Marketwire (Tue, May 19) Wed, Apr 22, 2009 • Lorus Therapeutics Announces Presentation of New Supportive Data for LOR-2040 in Acute Myeloid Leukemia CCNMatthews (Wed, Apr 22) • Lorus Therapeutics Announces Presentation of New Supportive Data for LOR-2040 in Acute Myeloid Leukemia Marketwire (Wed, Apr 22) Mon, Apr 20, 2009 • Lorus Therapeutics Presents New Findings for First-in-class Anticancer Drug Candidate LOR-253 CCNMatthews (Mon, Apr 20) • Lorus Therapeutics Presents New Findings for First-in-class Anticancer Drug Candidate LOR-253 Marketwire (Mon, Apr 20) Wed, Apr 15, 2009 • Lorus Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors CCNMatthews (Wed, Apr 15) • Lorus Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors Marketwire (Wed, Apr 15) Mon, Apr 13, 2009 • Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2009 CCNMatthews (Mon, Apr 13) • Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2009 Marketwire (Mon, Apr 13) Older Headlines - Download Recent Headlines View headlines from: Mon, Apr 13, 2009Mon, Apr 6, 2009Mon, Mar 30, 2009Mon, Mar 23, 2009Mon, Mar 16, 2009Mon, Mar 9, 2009Mon, Mar 2, 2009Mon, Feb 23, 2009Mon, Feb 16, 2009Mon, Feb 9, 2009 Add LOR.TO News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage